Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:22 AM
Ignite Modification Date:
2025-12-25 @ 2:22 AM
NCT ID:
NCT05819034
Eligibility Criteria:
The inclusion criteria will be:
* Adolescents of both sexes with an age range between 10-17 years.
* They were diagnosed with Adolescent idiopathic scoliosis by an orthopedic specialist, confirmed through (loaded) X- rays.
* They have mild non-structural scoliosis with Cobb's angle measurement of between 10 and 25 degrees
* They have Single major thoracolumbar curve located between T6-7 to L1-2, apex at T12 or L1.
* They have good health conditions except for scoliosis.
* They can understand and communicate with no mental abnormalities.
The exclusion criteria will be:
* Adolescents with cerebral palsy or other degenerative neurological disorders;
* Participants with nutritional disorders e.g. diabetes or vascular disorders.
* Participants with a scoliotic curve with angle \> 25° will be excluded.
* Participants will be excluded from this study if they have inflexible spinal deformities interfering with spinal mobility,
* Participants who were subjected to any corrective surgery to their spine within the previous two years.
* Participants will be also excluded if their skin were sensitive or inflamed to any materials used.
* Participants who have seizures, perceptual disorders, visual problems, and auditory deficits
* Participants who have leg length discrepancy
* Participants who have scoliosis developed as a consequence of traumatic scoliosis.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
10 Years
Maximum Age:
17 Years
Study:
NCT05819034
Study Brief:
Protocol Section:
NCT05819034